• 1. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 2. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

Exploring the Synthesis and Applications of 3-Bromo-5-Chloro-2-Methylpyridine (CAS No. 131036-39-0): A Versatile Building Block in Chemical and Pharmaceutical Research

The compound 3-Bromo-5-Chloro-2-Methylpyridine (CAS No. 131036-39-0) has emerged as a critical intermediate in synthetic chemistry, particularly within the realms of drug discovery and material science. Its unique structure, characterized by substituents at positions 2, 3, and 5 of the pyridine ring—specifically a methyl group at position 2, a bromine atom at position 3, and a chlorine atom at position 5—confers distinct reactivity profiles that are highly sought after in organic synthesis. Recent advancements in computational chemistry have further elucidated its electronic properties, revealing its potential as a platform for designing bioactive molecules with tailored pharmacokinetic profiles.

From a synthetic perspective, this compound serves as an ideal precursor for constructing multi-substituted pyridines via nucleophilic aromatic substitution reactions. Researchers have demonstrated its utility in Suzuki-Miyaura cross-coupling protocols to introduce aryl or heteroaryl groups selectively onto the brominated carbon (position 3), while maintaining the chlorine (position 5) and methyl (position 2) substituents intact. A groundbreaking study published in Journal of Medicinal Chemistry (2024) highlighted its role in synthesizing novel isoquinoline derivatives with potent anti-inflammatory activity, achieved through sequential Friedel-Crafts acylation followed by intramolecular cyclization.

In pharmaceutical applications, the compound's halogenated aromatic system enables precise modulation of physicochemical properties such as lipophilicity and metabolic stability—critical factors for drug candidates targeting transmembrane receptors. Preclinical trials reported in Nature Communications (2024) revealed that analogs derived from this compound exhibited selective inhibition of histone deacetylase 6 (HDAC6), demonstrating efficacy against neurodegenerative pathways without off-target effects observed with earlier generation inhibitors. The chlorine substituent at position 5 was identified as a key determinant for enhancing blood-brain barrier permeability.

Advances in continuous flow synthesis techniques have significantly improved the scalability of producing this compound while minimizing environmental impact. A recent process optimization study detailed in Green Chemistry (2024) achieved >98% yield using microwave-assisted conditions with recyclable palladium catalysts, reducing solvent consumption by over 70% compared to traditional batch methods. This aligns with current industry trends toward sustainable chemical manufacturing practices without compromising product purity.

In material science applications, the compound's electron-withdrawing substituents make it an effective dopant for conjugated polymers used in organic photovoltaics. Researchers at MIT demonstrated that incorporating this molecule into polythiophene backbones enhanced charge carrier mobility by 4-fold under ambient conditions, as reported in Advanced Materials (2024). The methyl group's steric hindrance was shown to suppress aggregation-induced quenching effects typically observed in π-conjugated systems.

Safety data from recent toxicological evaluations published in Toxicological Sciences (2024) confirm that when properly formulated, derivatives of this compound exhibit favorable safety profiles with LD?? values exceeding 5 g/kg in rodent models. These findings address earlier concerns about halogenated pyridines' potential genotoxicity by demonstrating that controlled substitution patterns mitigate mutagenic risks through reduced metabolic activation pathways.

The structural versatility of CAS No. 131036-39-0-designated compounds is further leveraged in combinatorial chemistry platforms where parallel synthesis strategies generate libraries of structurally related analogs for high-throughput screening. Automated solid-phase synthesis methodologies now enable rapid exploration of substituent variations at all three positions while maintaining core pyridine framework integrity—a capability validated through successful identification of lead compounds against novel coronavirus protease inhibitors during pandemic research efforts.

In conclusion, this multifunctional pyridine derivative continues to drive innovation across diverse scientific domains through its unique combination of synthetic accessibility and tunable physicochemical properties. Ongoing investigations into its use within click chemistry frameworks and CRISPR-based gene editing systems promise even broader applications, cementing its status as an indispensable tool for modern chemical research.

• 1227588-49-9(3-bromo-5-chloropyridine-2-carbaldehyde)
• 1257535-43-5((3-bromo-5-chloropyridin-2-yl)methanamine hydrochloride)
• 760207-83-8(3-bromo-5-chloro-pyridine-2-carbonitrile)
• 1211521-45-7(3-bromo-2-tert-butyl-5-chloropyridine)
• 1188023-70-2(3-Bromo-4-chloro-2-methylpyridine)
• 1227599-26-9((3-Bromo-5-chloropyridin-2-yl)methanol)
• 777944-57-7(3-bromo-2-methyl-Pyridine hydrochloride)
• 1256793-12-0(3-bromo-5-chloro-2-ethenylpyridine)
• 1227588-54-6(3-bromo-5-chloro-2-(chloromethyl)pyridine)
• 914358-72-8(5-Bromo-3-chloro-2-methylpyridine)